ORIGINAL RESEARCH
Accepted on 17 Mar 2025
The development of a high-throughput acoustic droplet ejection massspectrometry assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of SLC1-A3, -A2 and -A1 in a drug discovery program
doi 10.3389/fphar.2025.1544682